Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1EYLEA Global
02 1EYLEA Outside of the United States
03 15Eylea
04 2Eylea (In United States)
05 1Eylea HD
06 1EyleaTM
07 8Zaltrap
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 30.20%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 76
2014 Revenue in Millions : 85
Growth (%) : 12%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 69
2015 Revenue in Millions : 82
Growth (%) : -16
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 93
2016 Revenue in Millions : 81
Growth (%) : 15
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 0
2017 Revenue in Millions : 85
Growth (%) : -100%
Main Therapeutic Indication : Ophthalmology
Currency : USD
2020 Revenue in Millions : 2,985
2019 Revenue in Millions : 3,017
Growth (%) : -1
Main Therapeutic Indication : Ophthalmology
Currency : USD
2019 Revenue in Millions : 4,644
2018 Revenue in Millions : 4,077
Growth (%) : 14
Main Therapeutic Indication : Ophthalmology
Currency : USD
2020 Revenue in Millions : 4,947
2019 Revenue in Millions : 4,644
Growth (%) : 7
Main Therapeutic Indication : Ophthalmology
Currency : USD
2021 Revenue in Millions : 3,213
2020 Revenue in Millions : 2,985
Growth (%) : 18
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 6
2019 Revenue in Millions : 7
Growth (%) : -21
LOOKING FOR A SUPPLIER?
